🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the effects of low-dose naltrexone (LDN) on childre...
Status
Unknown
Location
Jerusalem Institute for Child Development
Start Date
TBD
Trial ID
NCT00318162
Treatments Being Tested
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating c...
Status
Terminated
Location
Center for Pelvic Health at the NorthShore University HealthSystem
Start Date
2021-09-07
Trial ID
NCT04313972
Treatments Being Tested
The primary objective of the study is to determine the analgesic efficacy a...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2012-06
Trial ID
NCT01571362
Oral naltrexone was initially FDA approved to treat opioid use disorder and...
Status
Completed
Location
Washington University
Start Date
2019-09-01
Trial ID
NCT04409041
Treatments Being Tested
The investigators are testing treatment with low-dose naltrexone (LDN) for ...
Status
Recruiting
Location
Stanford University
Start Date
2015-06
Trial ID
NCT02502162
Background: Low-dose naltrexone (LDN) may be useful in managing the patholo...
Status
Unknown
Location
Parc Sanitari Sant Joan de Déu (PSSJD)
Start Date
2022-06-01
Trial ID
NCT04739995
Treatments Being Tested
The purpose of this pilot study is to determine if taking a low dose of nal...
Status
Completed
Location
Massachusetts General Hospital; Depression Research and Clinical Program
Start Date
2013-06
Trial ID
NCT01874951
Treatments Being Tested
This study aims to determine if low-dose naltrexone (LDN) reduces fatigue, ...
Status
Completed
Location
Women's Health Research Institute
Start Date
2024-01-15
Trial ID
NCT05430152
Treatments Being Tested
Treatment of chronic low-back pain with low-dose naltrexone and acetaminoph...
Status
Completed
Location
Annette C. Toledano, M.D.
Start Date
2017-08-15
Trial ID
NCT03201393
Treatments Being Tested
The ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Heal...
Status
Enrolling By Invitation
Location
Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)
Start Date
2025-10-23
Trial ID
NCT07221565